fluconazole and bradykinin

fluconazole has been researched along with bradykinin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Staercke, C; Hayek, S; Hooper, WC; Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM1
Ament, Z; Cheriyan, J; Griffin, JL; Gutterman, DD; Lazaar, AL; Mayer, RJ; Newby, DE; Tal-Singer, R; Wilkinson, IB; Yang, L1

Trials

2 trial(s) available for fluconazole and bradykinin

ArticleYear
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
    Journal of vascular research, 2014, Volume: 51, Issue:3

    Topics: Adult; Biological Factors; Bradykinin; Cytochrome P-450 Enzyme System; Female; Fluconazole; Forearm; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Potassium Channels, Calcium-Activated; Regional Blood Flow; Tetraethylammonium; Tissue Plasminogen Activator; Vasodilation

2014
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
    Chest, 2017, Volume: 151, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Adult; Aged; Blood Vessels; Bradykinin; Case-Control Studies; Cyclohexylamines; Endothelium, Vascular; Epoxide Hydrolases; Fluconazole; Forearm; Humans; In Vitro Techniques; Male; Middle Aged; Overweight; Plethysmography; Pulmonary Disease, Chronic Obstructive; Smoking; Triazines; Vasodilation; Vasodilator Agents

2017